Yana Najjar - UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA

基本信息

浏览量：49

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 103 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Advanced Stage Melanoma During Pregnancy: Real-world Management

Jessica S. W. Borgers,Douglas Buckner Johnson,Elisabeth Livingstone,Elizabeth Iannotti Buchbinder,William A. Robinson,Omid Hamid, Michelle Ferreira,Florentia Dimitriou, Georgina V. Long,Paolo Antonio Ascierto, Antonios Daletzakis,Yana G. Najjar,Geke Hospers, Jacob Seung Choi,Frederic Amant,Katy K. Tsai, Zeynep Eroglu,John Haanen,Isabella Claudia Glitza

Journal of Clinical Oncologyno. 16_suppl (2024): 9540-9540

引用0浏览0引用

Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after de fi nitive surgery: a multicenter, retrospective cohort study (vol 65, 102290, 2023)

ECLINICALMEDICINE (2024)

引用0浏览0引用

Initial Results from a Phase 1a/1b Study of STK-012, a First-in-class Α/β IL-2 Receptor Biased Partial Agonist in Advanced Solid Tumors (NCT05098132)

Benjamin Izar, Dmitriy Zamarin,David R. Spigel, Christopher J. Hoimes,David F. McDermott,Kartik Sehgal,Yana G. Najjar,Adam J. Schoenfeld,Edward B. Garon,Ryan J. Sullivan,Brian S. Henick,Ticiana A. Leal,Michael E. Hurwitz,Rana R. McKay,Natalie Busby,Anita Mehta-Damani,Alex Azrilevich,Tony Tran,Naiyer Rizvi,Martin Oft, Alexander I. Spira

CANCER RESEARCHno. 7 (2024)

引用0浏览0引用

Neoadjuvant Vidutolimod and Nivolumab in High-Risk Resectable Melanoma: A Prospective Phase II Trial

Diwakar Davar, Robert M Morrison, Amiran K Dzutsev,Arivarasan Karunamurthy, Joe-Marc Chauvin, Florent Amatore,Julie S Deutsch, Rodrigo X Das Neves,Richard R Rodrigues,John A McCulloch,Hong Wang, Douglas J Hartman, Jonathan H Badger, Miriam R Fernandes,Yulong Bai, Jie Sun, Alicia M Cole, Poonam Aggarwal, Jennifer R Fang,Christopher Deitrick, Riyue Bao, Umamaheswar Duvvuri,Shaum S Sridharan,Seungwon W Kim,Haroon A Choudry,Matthew P Holtzman, James F Pingpank, James Patrick O'Toole, Richelle DeBlasio, Yang Jin,Quanquan Ding,Wentao Gao, Christopher Groetsch,Ornella Pagliano,Amy Rose, Corey Urban, Jagjit Singh, Prajan Divarkar,David Mauro,Dmitri Bobilev,James Wooldridge,Arthur M Krieg,Matthew G Fury,Jeffrey R Whiteaker,Lei Zhao,Amanda G Paulovich,Yana G Najjar,Jason J Luke,John M Kirkwood,Janis M Taube,Hyun Jung Park,Giorgio Trinchieri, Hassane M Zarour

Cancer cellno. 11 (2024): 1898-1918.e12

引用0浏览0WOS引用

A Phase 1/2 Study of Vusolimogene Oderparepvec (RP1) in Primary Melanoma (mel) to Reduce the Risk of Sentinel Lymph Node (SLN) Metastasis

Jabra Zarka, Urvashi Mitbander,Joshi Amy Rose,Yan Zang,John M. Kirkwood,Jason J. Luke,Hassane M. Zarour,Diwakar Davar,Yana G. Najjar

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Automated Quantitative CD8+ Tumor-Infiltrating Lymphocytes and Tumor Mutation Burden As Independent Biomarkers in Melanoma Patients Receiving Front-Line Anti-PD-1 Immunotherapy

Dylan Fortman,Arivarasan Karunamurthy,Douglas Hartman,Hong Wang,Lindsey Seigh,Ibrahim Abukhiran,Yana G. Najjar,Liron Pantanowitz,Hassane M. Zarour,John M. Kirkwood,Diwakar Davar

The Oncologistno. 7 (2024): 619-628

引用0浏览0WOS引用

Abstract CT183: Initial results from a phase 1a/1b study of STK-012, a first-in-class α/β IL-2 receptor biased partial agonist in advanced solid tumors (NCT05098132)

Benjamin Izar,Dmitriy Zamarin, David R. Spigel, Christopher J. Hoimes,David F. McDermott,Kartik Sehgal,Yana G. Najjar,Adam J. Schoenfeld,Edward B. Garon,Ryan J. Sullivan,Brian S. Henick,Ticiana A. Leal,Michael E. Hurwitz,Rana R. McKay,Natalie Busby,Anita Mehta-Damani,Alex Azrilevich,Tony Tran,Naiyer Rizvi,Martin Oft,Alexander I. Spira

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

Combined Pd-1 and Ctla-4 Blockade in an International Cohort of Patients with Acral Lentiginous Melanoma

Erin McGillivray,Karam Ashouri,Eftychia Chatziioannou, Jesús Antonio Ocejo Gallegos,Jabra Zarka,Jacob Kechter,Angelina S Hwang,Kevin Zhang,Milton Barros, Justin Yeh, Ian Okazaki, Andrew B Crocker, Takuya Maeda,Soo J Park,Jacob Choi, Mia Andreoli, Tarneem Darwish, David J Savage,Kevin B Kim, Jayant Gupta, James Shen,Keisuke Shirai,April Choi,Lori Pai,Vinicius de Lima Vazquez,Justin Moser,Teresa Amaral, Leonel F Hernandez Aya,Jose Lutzky,Yana G Najjar,Collin M Costello,Aaron R Mangold,Shailender Bhatia,Geoffrey T Gibney,Jeffrey M Farma, Gregory A Daniels,Jeffrey Sosman,Sunandana Chandra,Ankit Mangla,Kathryn Bollin, Patrícia Abrão Possik, Carla Daniela Robles Espinoza,Fumito Ito,Gino K In

The British journal of dermatology (2024)

引用0浏览0WOS引用

Relapse-free Survival with Adjuvant Dabrafenib/trametinib Therapy after Relapse on a Prior Adjuvant CPI in BRAF V600-mutated Stage III/IV Melanoma

Jeffrey Weber, Waqas Haque, Svetomir N Markovic,April K S Salama,Inderjit Mehmi,Ryan J Sullivan,Yana G Najjar,Alexander C J van Akkooi, Alexander M Menzies,Georgina V Long,Amelia M Taylor,John Haanen,Lisanne P Zijlker, Keith L Davis,Siddharth Karanth, Deborah Norton, Lucy Connolly

The oncologist (2024)

引用0浏览0WOS引用

563 Microbe-rich TLS Drive TLS Activity and Immunotherapy Response in Melanoma Patients

Dipyaman Patra, Yan Zang, Tullia C Bruno,Yana G Najjar, Abigail E Overacre-Delgoffe

Regular and Young Investigator Award Abstracts (2024)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn